GSK-1292263

GSK-1292263 is a novel GPR119 receptor agonist and is used for the treatment of type 2 diabetes. GSK1292263 improves glucose regulation in animal models of diabetes, but has no effect on plasma glucose in type 2 diabetics.

Product Specifications

Shipping Conditions

Gel Pack

Storage Conditions

-20°C

Shelf Life

36 months

More Discoveries

Explore Other Products

Browse additional items from our catalog

NBP2-34555H 0.1 mL

Mouse Monoclonal Prolactin R Antibody (B6.2+PRLR742) [HRP]

View Details

345344-01 100 µL

PKA IIα reg discontinued

View Details

345344-02 200 µL

PKA IIα reg discontinued

View Details

TU222436 1.0 mL

Trim3 3'UTR Luciferase Stable Cell Line

View Details

E55A11240 100 µL

Human KLB/Beta-klotho Monoclonal Antibody

View Details

MBS7261453-01 48 Well

Canine Aldolase, ALD ELISA Kit

View Details